Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020052
Filing Date
2025-07-21
Accepted
2025-07-21 14:02:43
Documents
1
Period of Report
2025-07-21

Document Format Files

Seq Description Document Type Size
1 form4-07212025_060739.html 4  
1 form4-07212025_060739.xml 4 6669
  Complete submission text file 0001415889-25-020052.txt   8432
Mailing Address C/O ANTHERA PHARMACEUTICALS, INC. 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address
Leheny A. Rachel (Reporting) CIK: 0001484729 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39538 | Film No.: 251136800

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Issuer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)